Patent US4810699A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4810699A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted 1,3,4,9-tetrahydropyrano[3,4,-b]indole-1-acetic acids, pharmaceutical compositions containing them, and methods for treating inflammatory conditions and for analgesic purposes using them

Assignee: Wyeth LLC
•
Filing: 1987-09-21
•
Granted: 1989-03-07
•
Expires: 2007-09-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Indole derivatives characterized by having a 1,3,4,9-tetrahydropyrano[3,4-b]indole-1-acetic acid nucleus bearing a substituent in position 1,5, 6, 7 and 8. The derivatives are useful anti-inflammatory and analgesic agents and methods for their preparation and use are also disclosed.

Inventors

  • 👤 Joseph P. Sabatucci
  • 👤 Christopher A. Demerson
  • 👤 Amadeo A. Failli

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 07:15
CPC Classifications
C; C07; C07D; C07D491/00; C07D491/02; C07D491/04

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 48 words
The compounds having the structure ##STR5## wherein R 1 is hydrogen, lower alkyl containing 1 to 4 carbon atoms or halogen, R 2 is --O--CH 2 --CH═CH 2 , --O--CH 2 --CF 3 , --O--CH(CH 3 )--CF 3 , --O--CH 2 --C.tbd.CH and the pharmaceutically acceptable salts thereof.
Claim 2
Dependent Claim 48 words
The compounds having the structure ##STR5## wherein R 1 is hydrogen, lower alkyl containing 1 to 4 carbon atoms or halogen, R 2 is --O--CH 2 --CH═CH 2 , --O--CH 2 --CF 3 , --O--CH(CH 3 )--CF 3 , --O--CH 2 --C.tbd.CH and the pharmaceutically acceptable salts thereof.
Claim 3
Dependent Claim 26 words
The compounds according to claim 1 wherein R 1 is hydrogen or chlorine, R 2 is --O--CH 2 --CF 3 and the pharmaceutically acceptable salts thereof.
Claim 4
Dependent Claim 15 words
The compound according to claim 2 designated 7-chloro-1-ethyl-1,3,4,9-tetrahydro-8-(2,2,2-trifluoroethoxy)-pyrano[3,4-b]indole-1-acetic acid and the pharmaceutically acceptable salts thereof.
Claim 5
Dependent Claim 14 words
A compound according to claim 2 designated 1-ethyl-1,3,4,9-tetrahydro-8-(2,2,2-trifluoroethoxy)-pyrano[3,4-b]indole-1-acetic and the pharmaceutically acceptable salts thereof.
Claim 6
Dependent Claim 25 words
A pharmaceutical composition comprising a compound of structure (I), or a pharmaceutically acceptable salt thereof, as define in claim 1 and a pharmaceutically acceptable carrier.
Claim 7
Dependent Claim 51 words
A pharmaceutical composition comprising a compound of structure (I), or a pharmaceutically acceptable salt thereof, as defined in claim 1, a nonsteroid anti-inflammatory drug selected from the group consisting of, ibuprofen and aspirin, an opiate analgesic selected from the group consisting of codeine, oxycodone and morphine and a pharmaceutically acceptable carrier.
Claim 8
Dependent Claim 51 words
A method for treating inflammatory conditions and for analgesic purposes in conditions which require relief from pain in a mammal which comprises the administration to said mammal of an effective amount of a compound selected from those of formula (I), or a pharmaceutically acceptable salt thereof, as claimed in claim 1.
Claim 9
Dependent Claim 60 words
A method for treating inflammatory conditions and for analgesic purposes in conditions which require relief from pain in a mammal which comprises the administration to said mammal of an effective amount of a compound selected from those of formula (I), or a pharmaceutically acceptable salt thereof, as claimed in claim 1, in conjunction with nonsteroid anti-inflammatory drugs and opiate analgesics.

References Cited (Backward Citations)

US3843681A Cited
US3939178A Cited
US3974179A Cited
US4012417A Cited
US4585877A Cited
US4670462A Cited
US4686213A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1992-03-06 1992-09-05 1993-03-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1996-03-06 1996-09-05 1997-03-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2000-03-06 2000-09-05 2001-03-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag